Concepedia

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy

Pedro Xavier, Cristina Gamboa, Lucinda Calejo, Joaquina Silva, D.K. Stevenson, A. L. L. Nunes, José Martinez‐de‐Oliveira

European Journal of Obstetrics & Gynecology and Reproductive Biology · 2005 · 43 citations · 7 references

DOI

Concepts

References

7

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Carola Albano, R. Felberbaum, Johan Smitz et al. · Human Reproduction · 2000 · 312 citations · Full text

, , +13

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation

K. Diedrich, C. Diedrich, Eduarda M. Santos et al. · Human Reproduction · 1994 · 310 citations

, , +17

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

Margo R. Fluker, J. Grifo, Arthur Leader et al. · Fertility and Sterility · 2001 · 241 citations

, , +9

Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study.

F. Olivennes, Rénato Fanchin, P Bouchard et al. · PubMed · 1995 · 109 citations

, , +16

Human Oviductal Gonadotropin-Releasing Hormone: Possible Implications in Fertilization, Early Embryonic Development, and Implantation<sup>1</sup>

E.M. Casañ, Francisco Raga, Fernando Bonilla‐Musoles et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 66 citations · Full text

, , +17